A detailed history of Stokes Family Office, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Stokes Family Office, LLC holds 8,247 shares of NVO stock, worth $720,540. This represents 0.11% of its overall portfolio holdings.

Number of Shares
8,247
Previous 8,247 -0.0%
Holding current value
$720,540
Previous $1.18 Million 16.65%
% of portfolio
0.11%
Previous 0.14%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 05, 2024

BUY
$122.71 - $146.91 $33,377 - $39,959
272 Added 3.41%
8,247 $1.18 Million
Q4 2023

Feb 06, 2024

SELL
$87.78 - $105.45 $153,527 - $184,432
-1,749 Reduced 17.99%
7,975 $825,000
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $435,966 - $956,594
4,794 Added 97.24%
9,724 $884,000
Q2 2023

Aug 14, 2023

BUY
$155.98 - $172.65 $35,095 - $38,846
225 Added 4.78%
4,930 $797,000
Q1 2023

May 08, 2023

SELL
$132.34 - $159.14 $50,818 - $61,109
-384 Reduced 7.55%
4,705 $748,000
Q4 2022

Feb 14, 2023

BUY
$102.55 - $135.33 $16,510 - $21,788
161 Added 3.27%
5,089 $688,000
Q3 2022

Nov 10, 2022

SELL
$95.28 - $116.93 $13,148 - $16,136
-138 Reduced 2.72%
4,928 $491,000
Q2 2022

Aug 05, 2022

BUY
$103.24 - $121.81 $15,486 - $18,271
150 Added 3.05%
5,066 $565,000
Q1 2022

May 16, 2022

BUY
$93.1 - $112.54 $17,223 - $20,819
185 Added 3.91%
4,916 $546,000
Q4 2021

Feb 15, 2022

BUY
$95.88 - $117.08 $2,492 - $3,044
26 Added 0.55%
4,731 $530,000
Q3 2021

Nov 15, 2021

BUY
$84.42 - $106.62 $10,721 - $13,540
127 Added 2.77%
4,705 $452,000
Q2 2021

Aug 12, 2021

BUY
$67.66 - $84.76 $16,644 - $20,850
246 Added 5.68%
4,578 $384,000
Q1 2021

May 13, 2021

BUY
$67.06 - $75.82 $30,914 - $34,953
461 Added 11.91%
4,332 $291,000
Q3 2020

Nov 12, 2020

BUY
$63.69 - $70.22 $23,628 - $26,051
371 Added 10.6%
3,871 $269,000
Q2 2020

Aug 11, 2020

SELL
$58.54 - $67.94 $2,868 - $3,329
-49 Reduced 1.38%
3,500 $229,000
Q4 2019

Feb 10, 2020

BUY
$49.86 - $58.26 $176,953 - $206,764
3,549 New
3,549 $205,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Stokes Family Office, LLC Portfolio

Follow Stokes Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stokes Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stokes Family Office, LLC with notifications on news.